Showing results (1931-1940 of 2,945) with videos related to
Sort By:
Pageof 295
Frontiers in Immunology|December 15, 2025
The T385M STAT1 gain-of-function mutation confers the most severe disease outcomesRobert Torrance, Alexander J McKenna, Catherine King, et al.International Journal of Nanomedicine|March 27, 2020
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and FibrinolysisSebastian P Pernal, Alexander J Willis, Michael E Sabo, et al.Journal of Clinical Immunology|June 20, 2022
Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of ImmunityBethany Nicholson, Rupert Goodman, James Day, et al.Blood|September 23, 2010
Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemiaJing Chen, Mike Petrus, Bonita R Bryant, et al.Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2019
Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onsetGuoqiao Wang, Dean Coble, Eric M McDade, et al.Cancer Research|November 3, 2004
Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic miceYoshio Sakai, Brian J Morrison, J Douglas Burke, et al.International Journal for Parasitology|May 24, 2012
Extra-glycosomal localisation of Trypanosoma brucei hexokinase 2April C Joice, Todd L Lyda, Andrew C Sayce, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group BM P Kosty, S B Fleishman, J E Herndon, et al.Neuroscience Letters|November 24, 1999
Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03D Neill, M D Curran, D Middleton, et al.Pageof 295